Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20802526rdf:typepubmed:Citationlld:pubmed
pubmed-article:20802526lifeskim:mentionsumls-concept:C0031715lld:lifeskim
pubmed-article:20802526lifeskim:mentionsumls-concept:C0006772lld:lifeskim
pubmed-article:20802526lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:20802526lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:20802526pubmed:issue44lld:pubmed
pubmed-article:20802526pubmed:dateCreated2010-11-4lld:pubmed
pubmed-article:20802526pubmed:abstractTextFine tuning of Ras activity is widely known as a mechanism to induce different cellular responses. Recently, we have shown that calmodulin (CaM) binds to K-Ras and that K-Ras phosphorylation inhibits its interaction with CaM. In this study we report that CaM inhibits K-Ras phosphorylation at Ser181 by protein kinase C (PKC) in vivo, and this is a mechanism to modulate K-Ras activity and signaling. Although CaM inhibition increased the activation of endogenous K-Ras, PKC inhibition decreased its activation status. We demonstrate that K-Ras phosphorylation decreased susceptibility to p120GAP activity. Accordingly, we also observed that non-phosphorylable K-Ras mutant exhibits a less sustained activation profile and do not efficiently activate AKT at low growth factor doses compared with wild-type K-Ras. It is interesting that the physiological responses induced by K-Ras are affected by this phosphorylation; when K-Ras cannot be phosphorylated it exhibits a remarkably decreased ability to stimulate proliferation in non-saturated serum conditions. Finally, we demonstrate that phosphorylation also regulates oncogenic K-Ras functions, as focus formation capacity, mobility and apoptosis resistance upon adriamycin treatment of cells expressing oncogenic K-Ras that cannot be phosphorylated are highly compromised. Moreover, at low serum concentration proliferation and survival is practically inhibited when cells cannot phosphorylate oncogenic K-Ras. In this condition, K-Ras phosphorylation is essential to ensure a proper activation of mitogen-activated protein kinase and PI3K/AKT pathways. In summary, our findings suggest that the interplay between CaM interaction and PKC phosphorylation is essential to regulate non-oncogenic and oncogenic K-Ras activity and functionality.lld:pubmed
pubmed-article:20802526pubmed:languageenglld:pubmed
pubmed-article:20802526pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20802526pubmed:citationSubsetIMlld:pubmed
pubmed-article:20802526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20802526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20802526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20802526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20802526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20802526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20802526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20802526pubmed:statusMEDLINElld:pubmed
pubmed-article:20802526pubmed:monthNovlld:pubmed
pubmed-article:20802526pubmed:issn1476-5594lld:pubmed
pubmed-article:20802526pubmed:authorpubmed-author:BachsOOlld:pubmed
pubmed-article:20802526pubmed:authorpubmed-author:AgellNNlld:pubmed
pubmed-article:20802526pubmed:authorpubmed-author:López-AlcaláC...lld:pubmed
pubmed-article:20802526pubmed:authorpubmed-author:DrostenMMlld:pubmed
pubmed-article:20802526pubmed:authorpubmed-author:Alvarez-MoyaB...lld:pubmed
pubmed-article:20802526pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20802526pubmed:day4lld:pubmed
pubmed-article:20802526pubmed:volume29lld:pubmed
pubmed-article:20802526pubmed:ownerNLMlld:pubmed
pubmed-article:20802526pubmed:authorsCompleteYlld:pubmed
pubmed-article:20802526pubmed:pagination5911-22lld:pubmed
pubmed-article:20802526pubmed:meshHeadingpubmed-meshheading:20802526...lld:pubmed
pubmed-article:20802526pubmed:meshHeadingpubmed-meshheading:20802526...lld:pubmed
pubmed-article:20802526pubmed:meshHeadingpubmed-meshheading:20802526...lld:pubmed
pubmed-article:20802526pubmed:meshHeadingpubmed-meshheading:20802526...lld:pubmed
pubmed-article:20802526pubmed:meshHeadingpubmed-meshheading:20802526...lld:pubmed
pubmed-article:20802526pubmed:meshHeadingpubmed-meshheading:20802526...lld:pubmed
pubmed-article:20802526pubmed:meshHeadingpubmed-meshheading:20802526...lld:pubmed
pubmed-article:20802526pubmed:meshHeadingpubmed-meshheading:20802526...lld:pubmed
pubmed-article:20802526pubmed:meshHeadingpubmed-meshheading:20802526...lld:pubmed
pubmed-article:20802526pubmed:meshHeadingpubmed-meshheading:20802526...lld:pubmed
pubmed-article:20802526pubmed:meshHeadingpubmed-meshheading:20802526...lld:pubmed
pubmed-article:20802526pubmed:meshHeadingpubmed-meshheading:20802526...lld:pubmed
pubmed-article:20802526pubmed:year2010lld:pubmed
pubmed-article:20802526pubmed:articleTitleK-Ras4B phosphorylation at Ser181 is inhibited by calmodulin and modulates K-Ras activity and function.lld:pubmed
pubmed-article:20802526pubmed:affiliationDepartament de Biologia Cel.lular, Facultat de Medicina, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain.lld:pubmed
pubmed-article:20802526pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20802526pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20802526lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20802526lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20802526lld:pubmed